PharmaCyte Biotech, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q2 2024.
  • PharmaCyte Biotech, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending July 31, 2024 was 7.87M shares, a 37.6% decline year-over-year.
  • PharmaCyte Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 9.58M shares, a 50.8% decline from 2022.
  • PharmaCyte Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 19.5M shares, a 25.6% increase from 2021.
  • PharmaCyte Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 15.5M shares, a 972% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 7.87M -4.74M -37.6% May 1, 2024 Jul 31, 2024 10-Q 2024-09-17
Q1 2024 9.58M -9.91M -50.8% Feb 1, 2024 Apr 30, 2024 10-K 2024-08-13
Q4 2023 8.61M -10.4M -54.7% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 8.77M -11.8M -57.4% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-15
Q2 2023 12.6M -8.23M -39.5% May 1, 2023 Jul 31, 2023 10-Q 2024-09-17
Q1 2023 19.5M +3.97M +25.6% Feb 1, 2023 Apr 30, 2023 10-K 2024-08-13
Q4 2022 19M -2.67M -12.3% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 20.6M +3.23M +18.6% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 20.8M +19.2M +1209% May 1, 2022 Jul 31, 2022 10-Q 2023-09-18
Q1 2022 15.5M +14.1M +972% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-31
Q4 2021 21.7M +20.1M +1291% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 17.4M +15.8M +1028% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
Q2 2021 1.59M +472K +42.2% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 1.45M +544K +60.2% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-28
Q4 2020 1.56M -1.37B -99.9% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 1.54M -1.32B -99.9% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-14
Q2 2020 1.12M -1.21B -99.9% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 904K -1.1B -99.9% Feb 1, 2020 Apr 30, 2020 10-K 2021-08-10
Q4 2019 1.38B +249M +22.1% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-12
Q3 2019 1.33B +244M +22.6% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 1.21B +164M +15.7% May 1, 2019 Jul 31, 2019 10-Q 2020-09-11
Q1 2019 1.1B +131M +13.6% Feb 1, 2019 Apr 30, 2019 10-K 2020-08-13
Q4 2018 1.13B +151M +15.5% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-13
Q3 2018 1.08B +108M +11.1% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-23
Q2 2018 1.05B +121M +13.1% May 1, 2018 Jul 31, 2018 10-Q 2019-09-13
Q1 2018 969M +123M +14.6% Feb 1, 2018 Apr 30, 2018 10-K 2019-08-13
Q4 2017 976M +116M +13.5% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-14
Q3 2017 973M +124M +14.6% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-14
Q2 2017 926M +137M +17.4% May 1, 2017 Jul 31, 2017 10-Q 2018-09-12
Q1 2017 845M +92.9M +12.3% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-20
Q4 2016 860M +103M +13.6% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 849M +104M +13.9% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-14
Q2 2016 788M +50.3M +6.81% May 1, 2016 Jul 31, 2016 10-Q 2017-09-13
Q1 2016 752M +48.1M +6.83% Feb 1, 2016 Apr 30, 2016 10-K 2017-07-27
Q4 2015 757M +60.5M +8.69% Nov 1, 2015 Jan 31, 2016 10-Q/A 2017-03-13
Q3 2015 745M +42M +5.98% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-02
Q2 2015 738M +36M +5.13% May 1, 2015 Jul 31, 2015 10-Q 2016-09-06
Q1 2015 704M +121M +20.8% Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 696M +96.2M +16% Nov 1, 2014 Jan 31, 2015 10-Q 2015-03-13
Q3 2014 703M +162M +29.9% Aug 1, 2014 Oct 31, 2014 10-Q 2014-12-15
Q2 2014 702M +180M +34.5% May 1, 2014 Jul 31, 2014 10-Q 2014-09-15
Q1 2014 583M +142M +32.3% Feb 1, 2014 Apr 30, 2014 10-K 2016-07-29
Q4 2013 600M +155M +34.9% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-13
Q3 2013 541M +112M +26% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 522M +102M +24.4% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 441M +66.2M +17.7% Feb 1, 2013 Apr 30, 2013 10-K/A 2016-01-19
Q4 2012 445M +71.3M +19.1% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 429M +55.4M +14.8% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-16
Q2 2012 420M +52.3M +14.2% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 375M +24.4M +6.97% Feb 1, 2012 Apr 30, 2012 10-K 2013-07-29
Q4 2011 373M +25M +7.16% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-26
Q3 2011 374M +25.7M +7.38% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-26
Q2 2011 367M +18.9M +5.43% May 1, 2011 Jul 31, 2011 10-Q 2012-09-19
Q1 2011 350M Feb 1, 2011 Apr 30, 2011 10-K 2012-08-14
Q4 2010 348M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
Q3 2010 348M Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
Q2 2010 348M May 1, 2010 Jul 31, 2010 10-Q/A 2011-09-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.